426 related articles for article (PubMed ID: 10389995)
1. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study.
Lange N; Jichlinski P; Zellweger M; Forrer M; Marti A; Guillou L; Kucera P; Wagnières G; van den Bergh H
Br J Cancer; 1999 Apr; 80(1-2):185-93. PubMed ID: 10389995
[TBL] [Abstract][Full Text] [Related]
2. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer.
Marti A; Jichlinski P; Lange N; Ballini JP; Guillou L; Leisinger HJ; Kucera P
J Urol; 2003 Aug; 170(2 Pt 1):428-32. PubMed ID: 12853792
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of an iron chelator (CP94) in increasing cellular protoporphyrin IX following intravesical 5-aminolaevulinic acid administration: an in vivo study.
Chang SC; MacRobert AJ; Porter JB; Bown SG
J Photochem Photobiol B; 1997 Apr; 38(2-3):114-22. PubMed ID: 9203372
[TBL] [Abstract][Full Text] [Related]
4. Protoporphyrin IX-accumulation in human tumor cells following topical ALA- and h-ALA-application in vivo.
Zenzen V; Zankl H
Cancer Lett; 2003 Dec; 202(1):35-42. PubMed ID: 14643024
[TBL] [Abstract][Full Text] [Related]
5. Topical application of 5-aminolevulinic acid hexyl ester and 5-aminolevulinic acid to normal nude mouse skin: differences in protoporphyrin IX fluorescence kinetics and the role of the stratum corneum.
van den Akker JT; Iani V; Star WM; Sterenborg HJ; Moan J
Photochem Photobiol; 2000 Nov; 72(5):681-9. PubMed ID: 11107855
[TBL] [Abstract][Full Text] [Related]
6. The monitoring of the accumulation of protoporphyrin IX in Walker tumours by subcutaneous administration of delta-aminolevulinic acid.
Calin MA; Gruia Ml; Herascu N; Coman T
J Exp Ther Oncol; 2004 Oct; 4(3):247-51. PubMed ID: 15724844
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence characteristics and pharmacokinetic properties of a novel self-adhesive 5-ALA patch for photodynamic therapy of actinic keratoses.
Fauteck JD; Ackermann G; Birkel M; Breuer M; Moor AC; Ebeling A; Ortland C
Arch Dermatol Res; 2008 Feb; 300(2):53-60. PubMed ID: 17960406
[TBL] [Abstract][Full Text] [Related]
8. The fluorescence biodistribution and kinetics of aminolevulinic acid induced protoporphyrin IX in the bladder of a rat model with orthotopic urothelial carcinoma.
Gronlund-Pakkanen S; Wahlfors J; Makinen K; Pakkanen TM; Talja M; Ala-Opas M; Alhava E; Moore RB
J Urol; 2002 Apr; 167(4):1848-53. PubMed ID: 11912446
[TBL] [Abstract][Full Text] [Related]
9. In vitro/in vivo correlations between transdermal delivery of 5-aminolaevulinic acid and cutaneous protoporphyrin IX accumulation and effect of formulation.
Tsai JC; Chen IH; Wong TW; Lo YL
Br J Dermatol; 2002 May; 146(5):853-62. PubMed ID: 12000384
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the pharmacokinetics and phototoxicity of protoporphyrin IX metabolized from 5-aminolevulinic acid and two derivatives in human skin in vivo.
Gerscher S; Connelly JP; Griffiths J; Brown SB; MacRobert AJ; Wong G; Rhodes LE
Photochem Photobiol; 2000 Oct; 72(4):569-74. PubMed ID: 11045731
[TBL] [Abstract][Full Text] [Related]
11. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy.
Loh CS; MacRobert AJ; Bedwell J; Regula J; Krasner N; Bown SG
Br J Cancer; 1993 Jul; 68(1):41-51. PubMed ID: 8318419
[TBL] [Abstract][Full Text] [Related]
12. Topical application of 5-aminolaevulinic acid, methyl 5-aminolaevulinate and hexyl 5-aminolaevulinate on normal human skin.
Juzeniene A; Juzenas P; Ma LW; Iani V; Moan J
Br J Dermatol; 2006 Oct; 155(4):791-9. PubMed ID: 16965430
[TBL] [Abstract][Full Text] [Related]
13. Protoporphyrin IX distribution following local application of 5-aminolevulinic acid and its esterified derivatives in the tissue layers of the normal rat colon.
Endlicher E; Rümmele P; Hausmann F; Krieg R; Knüchel R; Rath HC; Schölmerich J; Messmann H
Br J Cancer; 2001 Nov; 85(10):1572-6. PubMed ID: 11720447
[TBL] [Abstract][Full Text] [Related]
14. A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose-controlled delivery of the prodrugs 5-aminolaevulinic acid and 5-aminolaevulinic acid-n-pentylester.
Gerscher S; Connelly JP; Beijersbergen Van Henegouwen GM; MacRobert AJ; Watt P; Rhodes LE
Br J Dermatol; 2001 May; 144(5):983-90. PubMed ID: 11359385
[TBL] [Abstract][Full Text] [Related]
15. Novel patch-based systems for the localised delivery of ALA-esters.
Morrow DI; McCarron PA; Woolfson AD; Juzenas P; Juzeniene A; Iani V; Moan J; Donnelly RF
J Photochem Photobiol B; 2010 Oct; 101(1):59-69. PubMed ID: 20634088
[TBL] [Abstract][Full Text] [Related]
16. Biodistribution of protoporphyrin IX in rat urinary bladder after intravesical instillation of 5-aminolevulinic acid.
Chang SC; MacRobert AJ; Bown SG
J Urol; 1996 May; 155(5):1744-8. PubMed ID: 8627876
[TBL] [Abstract][Full Text] [Related]
17. Penetration enhancement of two topical 5-aminolaevulinic acid formulations for photodynamic therapy by erbium:YAG laser ablation of the stratum corneum: continuous versus fractional ablation.
Forster B; Klein A; Szeimies RM; Maisch T
Exp Dermatol; 2010 Sep; 19(9):806-12. PubMed ID: 20636354
[TBL] [Abstract][Full Text] [Related]
18. Biodistribution of Photofrin II and 5-aminolevulinic acid-induced protoporphyrin IX in normal rat bladder and bladder tumor models: implications for photodynamic therapy.
Xiao Z; Miller GG; McCallum TJ; Brown KM; Lown JW; Tulip J; Moore RB
Photochem Photobiol; 1998 May; 67(5):573-83. PubMed ID: 9613241
[TBL] [Abstract][Full Text] [Related]
19. Comparison of ALA- and ALA hexyl-ester-induced PpIX depth distribution in human skin carcinoma.
Dögnitz N; Salomon D; Zellweger M; Ballini JP; Gabrecht T; Lange N; van den Bergh H; Wagnières G
J Photochem Photobiol B; 2008 Dec; 93(3):140-8. PubMed ID: 18818091
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence diagnosis of bladder cancer: a novel in vivo approach using 5-aminolevulinic acid (ALA) dendrimers.
François A; Battah S; MacRobert AJ; Bezdetnaya L; Guillemin F; D'Hallewin MA
BJU Int; 2012 Dec; 110(11 Pt C):E1155-62. PubMed ID: 22883132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
